Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3830)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 15, 2023 (publication date) through Jul 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fang YT, Yang WW, Niu YR, Sun YK. Recent advances in targeted therapy for pancreatic adenocarcinoma. World J Gastrointest Oncol 2023; 15(4): 571-595 [PMID: 37123059 DOI: 10.4251/wjgo.v15.i4.571] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i4/571.htm |
| Number | Citing Articles |
| 1 |
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, Patrizia Diana, Elisa Giovannetti, Daniela Carbone. Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma. Future Medicinal Chemistry 2024; 16(3): 271 doi: 10.4155/fmc-2023-0234
|
| 2 |
Chunxiao Ren, Yuqun Wang, Xin Yang, Yinglan Tuo, Yaqiong Li, Jichang Gong. Kikuchi disease: A case report about Sintilimab-induced Kikuchi histiocytic necrotizing lymphadenitis and literature review. Heliyon 2024; 10(9): e30608 doi: 10.1016/j.heliyon.2024.e30608
|
| 3 |
Diego J. Jiménez, Aadil Javed, Teresa Rubio-Tomás, Ndioba Seye-Loum, Carles Barceló. Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences 2024; 25(5): 2860 doi: 10.3390/ijms25052860
|
| 4 |
Karl Knipper, Yussra Hussein, Adrian Georg Simon, Caroline Fretter, Alexander I. Damanakis, Yue Zhao, Christiane J. Bruns, Thomas Schmidt, Felix C. Popp, Alexander Quaas, Su Ir Lyu, Michael Heise, Frank Marusch, Marco Siech, Tawfik Mosa, Bodo Schniewind, Jürgen Tepel, Werner Hartwig, Christoph Prinz, Bettina M. Rau, Marco Niedergethmann, Rainer Kube, George Saada, Wolfgang Hiller, Utz Settmacher. Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05681-x
|
| 5 |
Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, Hiroyuki Shibata, Atsushi Sato, Kazunori Otsuka, Kenji Amagai, Masanobu Takahashi, Takuhiro Yamaguchi, Chikashi Ishioka. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201). BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11973-9
|
| 6 |
Jinglong Guo, Siyue Wang, Qi Gao. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1258538
|
| 7 |
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, Kazem Jamali, Amin Moradi Hasan-Abad, Amir Atapour, Gholamreza Anani Sarab. The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1355064
|
| 8 |
Chao Liu, Jiang Du, Jianwei Zheng, Ruizhe Zhang, Jialin Zhu, Bofan Xing, Lin Dong, Qianqian Zhou, Xiaofeng Yao, Song Gao, Yu Wang, Yu Ren, Xuan Zhou. The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1151321
|
| 9 |
Su Ir Lyu, Caroline Fretter, Adrian Georg Simon, Sarah-Michele Spielmann, Alexander I. Damanakis, Yue Zhao, Christiane J. Bruns, Thomas Schmidt, Felix C. Popp, Dirk Waldschmidt, Alexander Quaas, Karl Knipper. Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence. Translational Oncology 2024; 47: 102044 doi: 10.1016/j.tranon.2024.102044
|
| 10 |
Kritisha Bhandari, Wei-Qun Ding. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. International Journal of Molecular Sciences 2024; 25(7): 3958 doi: 10.3390/ijms25073958
|
| 11 |
Clare Chen, Lusine Demirkhanyan, Christopher S. Gondi. The Multifaceted Role of miR-21 in Pancreatic Cancers. Cells 2024; 13(11): 948 doi: 10.3390/cells13110948
|
| 12 |
Deepak Bhamidipati, Sireesha Yedururi, Jason Huse, Sri Veda Chinapuvvula, Jie Wu, Vivek Subbiah. Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.23.00252
|
| 13 |
Boyu Qin, Qi Xiong, Lingli Xin, Ke Li, Weiwei Shi, Qi Song, Qiong Sun, Jiakang Shao, Jing Zhang, Xiao Zhao, Jinyu Liu, Jinliang Wang, Bo Yang. Synergistic effect of additional anlotinib and immunotherapy as second‐line or later‐line treatment in pancreatic cancer: A retrospective cohort study. Cancer Innovation 2024; 3(4) doi: 10.1002/cai2.123
|
| 14 |
Akash Bararia, Amlan Das, Sangeeta Mitra, Sudeep Banerjee, Aniruddha Chatterjee, Nilabja Sikdar. Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. World Journal of Gastrointestinal Oncology 2023; 15(9): 1505-1519 doi: 10.4251/wjgo.v15.i9.1505
Abstract(351) |
Core Tip(392) |
Full Article(HTML)(2815)
|
Full Article with Cover (PDF)-2302K(64)
|
Full Article (Word)-641K(41)
|
Audio-449K(1)
|
Peer-Review Report-207K(40)
|
Answering Reviewers-146K(42)
|
Full Article (PDF)-2009K(110)
|
Full Article (XML)-278K(44)
|
Times Cited (0)
|
Total Visits (5306)
|
Open
|